Freedom of Information

Title
Products containing Chitin or Chitosan
Reference Number
RF23-403
Request Details
  1. Does any of the product(s) purchased/used in your hospital contain Chitin/Chitosan (e.g. surgical sutures, materials in wound healing/tissue engineering/dentistry/drug delivery)? YES/NO

If the answer to Q1 is Yes then skip to Q3.
If the answer to Q1 is No then:

  1. Do you plan on utilizing products containing Chitin/Chitosan in the next two years? YES/NO Dominic/Sarah

If the answer to Q2 is No, you may skip the rest of the questionnaire.
If the answer to Q2 is Yes, answer Q3 and then you may skip the rest of the questionnaire.

  1. What product(s) do you have in the hospital (or intend to purchase) that contain Chitin/Chitosan?

For each product listed please provide the following details:
a. The product's brand name.
b. The purpose of the product and in which department it is used.
c. The approximate volume of the product used/purchased over the last financial year (1st April 2022 – 31st March 2023).

  1. Has the hospital received any complaints or filed any cases of side effects from using the Chitin/Chitosan product(s) mentioned above? If so, please provide detail of the following:

a. Number of cases in years 2020, 2021, 2022 and 2023
b. description of the most three common side effects
c. Which product(s) caused the most commonly seen side effects

  1. Is there any limitation(s), certification(s), or regulatory requirement(s) that are bounded when utilizing Chitin/Chitosan in the hospital (i.e. ISO standards or Ethics, etc)? If so, please specify.

  2. Is the hospital currently or will be promoting any new products containing chitin or chitosan?

Response
  • rf23-403-response.pdf
  • Date of Disclosure
    18/07/2023